NCT03937154 2026-01-27
Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Non-small Cell Lung Cancer (NSCLC), Ovarian Cancer, or Breast Cancer
Amgen
Phase 3 Active not recruiting
Amgen
Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH